Walid Kamoun, Vice President, Global Head of R&D Oncology at Servier, shared a post on LinkedIn:
“Back from ASCO2026 energized and inspired
The ASCO Annual Meeting is always a unique moment to step back from the day-to-day and reconnect with the broader oncology community in what feels, at times, like a quasi-spiritual gathering around a shared mission.
This year felt exceptional. We witnessed remarkable data, including a standing ovation for results that will redefine the standard of care in pancreatic cancer. Progress in this field is hard-won, and the addition of a new therapy brings meaningful hope to patients.
Beyond the science, ASCO is about dialogue. I spent time engaging with investigators on how to best develop our therapies, and with current and future partners on how we can work together to bring transformative innovation to patients.
As I head back to Paris, I do so with energy, new ideas, and a renewed conviction that, together, we can accelerate progress and bring real hope to patients.
Thanks to all the Servier Oncology team for the great organization.”
More posts featuring Walid Kamoun.